SCHEMBL753793

SCHEMBL753793

CC(=O)N(CC1CCN(c2ncc(C(=O)NO)cn2)CC1)C(C)/C=C/c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 20/20 0.63
HDAC3 O15379 19/20 0.63
HDAC1 Q13547 19/20 0.63
HDAC2 Q92769 19/20 0.63
HDAC8 Q9BY41 19/20 0.63
HDAC4 P56524 18/20 0.63
HDAC7 Q8WUI4 18/20 0.63
HDAC10 Q969S8 18/20 0.63
HDAC11 Q96DB2 18/20 0.63
HDAC9 Q9UKV0 18/20 0.63
HDAC5 Q9UQL6 18/20 0.63
NCOR2 Q9Y618 2/20 0.47
PIK3CD O00329 1/20 0.47
PIK3CA P42336 1/20 0.47
PIK3CB P42338 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754773 0.92 HDAC6 (0.51) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL754772 0.87 HDAC3 (0.47) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL753795 0.87 HDAC6 (0.62) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL763165 0.85 HDAC3 (0.46) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL754792 0.81 HDAC6 (0.78) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL754643 0.78 HDAC6 (0.51) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL754727 0.77 HDAC3 (1.00) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL8273529 0.76 HDAC3 (1.00) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL754645 0.75 HDAC3 (1.00) HDAC6HDAC3HDAC1HDAC2HDAC8
SCHEMBL8251590 0.74 TRPM8 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8377935-B2 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase JANSSEN PHARMACEUTICA N.V. (BE) 2013-02-19 US disclosed
US-20120157456-A1 SUBSTITUTED AMINOPROPENYL PIPERIDINE OR MORPHOLINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE JANSSEN PHARMACEUTICA N.V. (BE) 2012-06-21 US disclosed
US-8138198-B2 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase ANGIBAUD PATRICK RENE (FR) 2012-03-20 US disclosed
US-8138198-B2 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase ANGIBAUD PATRICK RENE (FR) 2012-03-20 US disclosed
US-20090221580-A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase ANGIBAUD PATRICK RENE 2009-09-03 US disclosed
US-20090221580-A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase ANGIBAUD PATRICK RENE 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221580-A1 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase HDAC1, HDAC2, HDAC3 HDAC6 10/4885HDAC3 3/4885HDAC1 1/4885
US-20120157456-A1 SUBSTITUTED AMINOPROPENYL PIPERIDINE OR MORPHOLINE DERIVATIVES AS NOVEL INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC2, HDAC3 HDAC6 10/4885HDAC3 3/4885HDAC1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.